Paper353597
The treatment of hypertension with verapamil.
Lewis GR and 3 others. N Z Med J, 1978. Cited by 148 papers, by iCite.
Cite this record
ConductScience Library. The treatment of hypertension with verapamil. Papers, record 353597. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/353597
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hypertension | Major topic |
| Verapamil | Major topic |
| Adult | |
| Clinical Trials as Topic | |
| Dose-Response Relationship, Drug | |
| Double-Blind Method | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Placebos | |
| Posture |
Source PubMed
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 148 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32431612 | Verapamil and Alzheimer's Disease: Past, Present, and Future. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/32431612 | PubMed |
| 26823559 | Unravelling the complex drug-drug interactions of the cardiovascular drugs, verapamil and digoxin, with P-glycoprotein. | Biosci Rep | 2016 | https://conductscience.org/library/papers/26823559 | PubMed |
| 20166433 | Effects of simvastatin on the pharmacokinetics of verapamil and its main metabolite, norverapamil, in rats. | Eur J Drug Metab Pharmacokinet | 2009 | https://conductscience.org/library/papers/20166433 | PubMed |
| 20012601 | Pharmacokinetic interaction between oral lovastatin and verapamil in healthy subjects: role of P-glycoprotein inhibition by lovastatin. | Eur J Clin Pharmacol | 2010 | https://conductscience.org/library/papers/20012601 | PubMed |
| 18193210 | Drug interaction between oral atorvastatin and verapamil in healthy subjects: effects of atorvastatin on the pharmacokinetics of verapamil and norverapamil. | Eur J Clin Pharmacol | 2008 | https://conductscience.org/library/papers/18193210 | PubMed |
| 7512483 | Postinfarct treatment with verapamil. Effect of verapamil in patients with hypertension. | Drugs | 1993 | https://conductscience.org/library/papers/7512483 | PubMed |
| 7023517 | Role of calcium antagonists in cardiovascular therapy. | Br Heart J | 1981 | https://conductscience.org/library/papers/7023517 | PubMed |
| 7002568 | Antihypertensive and renal effects of orally administered verapamil. | Eur J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/7002568 | PubMed |
| 6831336 | Calcium blockers for cardiac disease: therapeutic implications. | Can Med Assoc J | 1983 | https://conductscience.org/library/papers/6831336 | PubMed |
| 6362951 | Clinical pharmacokinetics of verapamil. | Clin Pharmacokinet | 1984 | https://conductscience.org/library/papers/6362951 | PubMed |
| 6339198 | Calcium antagonists. Clinical use in the treatment of systemic hypertension. | Drugs | 1983 | https://conductscience.org/library/papers/6339198 | PubMed |
| 4027146 | Blood pressure, heart rate and A-V conduction responses to nicardipine in hypertensive patients receiving atenolol. | Br J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/4027146 | PubMed |
| 3896278 | Nicardipine hydrochloride in essential hypertension--a controlled study. | Br J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/3896278 | PubMed |
| 3803414 | Pharmacokinetics of verapamil in patients with hypertension. | Eur J Clin Pharmacol | 1986 | https://conductscience.org/library/papers/3803414 | PubMed |
| 3653223 | Assessment of 'once daily' verapamil for the treatment of hypertension using ambulatory, intra-arterial blood pressure recording. | Eur J Clin Pharmacol | 1987 | https://conductscience.org/library/papers/3653223 | PubMed |
| 3539623 | Sustained release verapamil in hypertension. Results from a noninvasive ambulatory blood pressure monitoring and a clinical study. | Eur J Clin Pharmacol | 1986 | https://conductscience.org/library/papers/3539623 | PubMed |
| 3530299 | Studies on verapamil in the treatment of essential hypertension: a review. | Br J Clin Pharmacol | 1986 | https://conductscience.org/library/papers/3530299 | PubMed |
| 3530297 | The management of hypertension. | Br J Clin Pharmacol | 1986 | https://conductscience.org/library/papers/3530297 | PubMed |
| 3294021 | Verapamil and bendrofluazide in the treatment of hypertension: a controlled study of effectiveness alone and in combination. | Eur J Clin Pharmacol | 1988 | https://conductscience.org/library/papers/3294021 | PubMed |
| 3154329 | Calcium channel antagonists. Part III: Use and comparative efficacy in hypertension and supraventricular arrhythmias. Minor indications. | Cardiovasc Drugs Ther | 1988 | https://conductscience.org/library/papers/3154329 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/353597
GET https://conductscience.org/api/papers/v1/353597/cited_by?page=2